Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 28.1
-8.86 %
$ 787 M
Market Cap
133.81
P/E
Price Target
Average
40.57%
Revenue Forecast
Estimate
13.50%
EBIT
Estimate
--5.82%
Net Income
Estimate
38.59%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Castle Biosciences, Inc.
Wall Street analysts predict an average 1-year price target for CSTL of $39.5 , with forecasts ranging from a low of $35 to a high of $45 .
CSTL Lowest Price Target
Wall Street Target
35 USD
24.56%
CSTL Average Price Target
Wall Street Target
39.5 USD
40.57%
CSTL Highest Price Target
Wall Street Target
45 USD
60.14%
REVENUE FORECAST
Revenue Forecast Chart CSTL
EBIT FORECAST
EBIT Forecast Chart CSTL
NET INCOME FORECAST
Net Income Chart CSTL